ASRT vs CE · rev $125.0M vs rev $10.28B
Assertio Therapeutics Inc (ASRT) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ASRT currently screens at market cap $151.5M. CE currently screens at market cap $5.92B.
Not investment advice. Open the ASRT and CE stock pages for the full models.
Not investment advice.